XPO1 inhibitor

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

XPO1 inhibitor
Treatment and conditionWhere it standsTrials
XPO1 inhibitor for lymphoma, extranodal nk-t-cellTrial registered, as of 19 Nov 2026 (not yet checked by a person)1